metformin and gsk-2816126

metformin has been researched along with gsk-2816126 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kong, Y; Li, Z; Liu, J; Liu, X; Mao, F; Wang, R; Zhang, Y; Zhang, Z	1

Other Studies

1 other study(ies) available for metformin and gsk-2816126

Article	Year
Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer. Molecular cancer therapeutics, 2020, Volume: 19, Issue:12 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Metformin; Mice; MicroRNAs; Promoter Regions, Genetic; Prostatic Neoplasms; Pyridones; Receptors, Androgen; Transcriptional Activation; Xenograft Model Antitumor Assays	2020

Article

Year

Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer.

Molecular cancer therapeutics, 2020, Volume: 19, Issue:12

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Indoles; Male; Metformin; Mice; MicroRNAs; Promoter Regions, Genetic; Prostatic Neoplasms; Pyridones; Receptors, Androgen; Transcriptional Activation; Xenograft Model Antitumor Assays

2020